International Bureau for Epilepsy Launches New Global Policy Advocacy Report at the 79th World Health Assembly
The International Bureau for Epilepsy (IBE) officially launched a new Policy Advocacy Report at...
Read More
Thank You to Our National Leadership Sponsor, Pendopharm
We are proud to recognize and thank our National Leadership Sponsor, Pendopharm, for their valued...
Read More
UNITED FOR AWARENESS: EPILEPSY CANADA & THE CANADIAN EPILEPSY ALLIANCE MARK EPILEPSY AWARENESS MONTH AND PURPLE DAY
FOR IMMEDIATE RELEASE UNITED FOR AWARENESS: EPILEPSY CANADA & THE CANADIAN EPILEPSY ALLIANCE...
Read More
SABRIL® (vigabatrin) 500 mg Powder: Stockout and Patient Guidance
At a Glance Affected Formulation: 500 mg powder for oral solution Tablet Form: 500 mg tablets...
Read More
Join Us in Raising Awareness for SUDEP Action Day – October 15, 2025
A Joint Initiative by the Canadian Epilepsy Alliance & Epilepsy Canada Too many families are...
Read More
Lundbeck Drug Shortage: SABRIL® (vigabatrin) powder for oral solution 500mg
The Canadian Epilepsy Alliance has been informed of an anticipated drug shortage that may affect...
Read More
Canadian Epilepsy Alliance Celebrates Major Milestone in Public Access to Xcopri® for Adults with Focal Seizures
Toronto, ON, June 27, 2025 – The Canadian Epilepsy Alliance (CEA) is celebrating a significant...
Read More
Making Music With Epilepsy
My name is Turner Bates. I am a 19-year-old living in Cochrane, just outside of my hometown of...
Read More
Canadian Epilepsy Alliance Celebrates Progress on Xcopri Access, Calls on Provinces to Act Quickly for Patients
Toronto, ON, April 9, 2025 – The Canadian Epilepsy Alliance (CEA) is celebrating a major step...
Read More
TEVA-CLOBAZAM (clobazam) 10 mg Tablets, is again available at Canadian pharmacies following a temporary shortage.
Patients are advised to speak with their local pharmacist, a vital and accessible healthcare...
Read More
PATIENT GROUP STEPS UP ITS NATIONAL CAMPAIGN FOR PROVINCIAL COVERAGE OF “LIFE-CHANGING” EPILEPSY TREATMENT
Effective new treatment for uncontrolled epilepsy remains out of reach for those who need it most,...
Read More
Hope for epilepsy patients: Join the movement to make Xcopri accessible across Canada
Cenobamate (Xcopri) is a groundbreaking medication offering hope to people living with...
Read More